Shanghai Pharmaceuticals Holding Co., Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPMF research report →
Price Chart
About the company
Shanghai Pharmaceuticals Holding Co. , Ltd. functions as an investment holding company deeply involved in various facets of China's pharmaceutical and healthcare sectors.
- CEO
- Qiuhua Yang
- IPO
- 2013
- Employees
- 49,608
- HQ
- Shanghai, SHA, CN
Get TickerSpark's AI analysis on SHPMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $8.46B
- P/E
- 12.93
- Fwd P/E
- 0.99
- PEG
- -0.62
- P/S
- 0.21
- P/B
- 0.79
- EV/EBITDA
- 7.52
- Div Yield
- 3.42%
- Gross Margin
- 10.79%
- Op Margin
- 2.78%
- Net Margin
- 1.65%
- ROE
- 6.21%
- ROIC
- 3.64%
Latest fiscal year · YoY change
- Revenue
- $283.58B+3.0%
- Gross Profit
- $30.42B-0.7%
- Op Income
- $9.94B
- Net Income
- $5.72B+25.7%
- EPS
- $1.54+25.2%
- OCF Growth
- +5.6%
- FCF Growth
- +11.7%
- 52W High
- $15.70
- 52W Low
- $1.46
- 50D MA
- $1.49
- 200D MA
- $1.53
- Beta
- 0.16
- RSI (14)
- 0
- Avg Volume
- 1
No earnings-call transcripts are available for SHPMF yet.
- Free Float
- 27.0%
- Shares Outstanding
- 5.79B
- Float Shares
- 1.56B
Our SHPMF coverage
Recent articles, reports, and earnings notes.
No research on SHPMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHPMF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.